Stem Cell Research

Biotechnology Research to Grow From Embryonic Start

Published in Blood Weekly, September 21st, 2000

The Adelaide, Australia-based biotechnology company, BresaGen, expects to receive human embryonic stem (ES) cells in the near future from the University of Wisconsin, USA.

The cells are intended for use in the BresaGen Cell Therapy Program, which is conducted in the Department of Biochemistry at Adelaide University under the scientific direction of Prof. Peter Rathjen.

Stem cells are embryonic cells, among the first to appear as a fertilized egg develops. They have the ability to develop into most of the specialized cells in the human body including blood, skin, muscle, and nerve cells. They also have the capacity to divide and proliferate...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2000-09-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry